To establish whether heterogeneous gene expression of multiple NF-κB components can confer distinct basal NF-κB activation and response to TME, we simulated the RIVA and U2932 cell lines, which show similar expression of NF-κB target genes and are both ABC-DLBCL cell lines. The gene discussed is NFKB1; the disease is aneurysmal bone cyst.